|
Pfizer Launches Five Year, Three Country Initiative for Malaria Treatment and Education |
|
Thursday, 06 September 2007 |
To help address critical gaps in malaria treatment and education, Pfizer today announced the launch of Mobilize Against Malaria. This three-country initiative comprising Kenya, Ghana and Senegal will be implemented over the course of five years (2007-2011). Pfizer has selected key international and local health experts to develop and implement public health interventions that engage and educate treatment providers and patients in high-risk areas for the effective treatment and management of malaria. |
|
Read more...
|
|
|
Novo Nordisk Appoints New Leaders of European and North American Regions |
|
Wednesday, 05 September 2007 |
Novo Nordisk announced that with effect from 1 January 2008 the company has appointed Martin Soeters to take up the position as senior vice president of Region Europe. Martin Soeters is currently senior vice president of Novo Nordisk North America and president of Novo Nordisk Inc., the company's US affiliate. Martin Soeters will be replaced by Jerzy Gruhn who will take up the position as senior vice president of Novo Nordisk North America from the same date. Jerzy Gruhn is currently vice president of the Europe East region within Region Europe. |
|
Read more...
|
|
|
AstraZeneca Enhances Clinical Research Capabilities in China |
|
Tuesday, 04 September 2007 |
AstraZeneca today announced a strategic partnership with Peking University 3rd Hospital to open its first Clinical Pharmacology Unit (CPU) in China. The unit aims to enhance local clinical research capabilities and speed up access to new medicines to benefit Chinese patients. |
|
Read more...
|
|
|
Journalists from Argentina and Greece win Novo Nordisk Media Prize 2007 |
|
Wednesday, 29 August 2007 |
Journalists Gabriela Navarra from Argentina and Michael Kefalogiannis from Greece won the Novo Nordisk Media Prize 2007 for the best article in lay press and the best TV feature about diabetes, respectively. The awards were presented by the president and CEO of Novo Nordisk, Lars Rebien Sørensen, during a ceremony held on 28 August in Copenhagen. |
|
Read more...
|
|
|
InferMed appoints Cancer Research UK's Dr Sally Burtles as Observer to the Board |
|
Tuesday, 28 August 2007 |
|
InferMed, a leading provider of advanced software solutions for clinical research and practice, has appointed Dr Sally Burtles, Director of Drug Development at Cancer Research UK, as an Observer to the Board.
InferMed has a long-standing relationship with Cancer Research UK, and was backed by the charity at its formation in 1999. A research relationship continues with Cancer Research UK, which remains InferMed's largest institutional shareholder. |
|
Read more...
|
|
|
Pfizer Names Frank A. D'Amelio Chief Financial Officer |
|
Wednesday, 22 August 2007 |
Pfizer today announced that Frank A. D'Amelio, a senior executive with almost three decades of extensive operating and financial experience at AT&T, Lucent Technologies and Alcatel-Lucent, including serving as both chief operating officer and chief financial officer at Lucent, will become Pfizer’s Senior Vice President and Chief Financial Officer effective in mid-September. |
|
Read more...
|
|
|
GlaxoSmithKline Signs Contract for its Pandemic Flu Vaccine with UK Government |
|
Thursday, 16 August 2007 |
GlaxoSmithKline (GSK) today announced that it has entered into an agreement with the UK Government to provide its pandemic influenza vaccine in the event of a flu pandemic. It is one of the largest contracts signed by GSK to date for its proprietary adjuvanted pandemic flu vaccine. |
|
Read more...
|
|
|
Novartis Completes Divestment of Medical Nutrition Business |
|
Monday, 02 July 2007 |
Novartis has completed the sale of its Medical Nutrition business to Nestlé for USD 2.5 billion, one of the final steps in a divestment program to focus the Group's strategy on healthcare with pharmaceuticals at the core. |
|
Read more...
|
|
|
<< Start < Prev 11 Next > End >>
|
| Results 101 - 108 of 108 |